Syphilis natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 4: Line 4:


== Overview ==
== Overview ==
Initial presentation of syphilis is appearance of painless chancre after 3-4 weeks of exposure. If left untreated, chancre self resolves and may progress to develop [[constitutional sypmtoms]] and generalised symmetric rash in four to eight weeks. In less than 10% of individuals, complications such as [[hepatitis]], [[iritis]], [[nephritis]], and neurological problems may develop at this stage. However, it resolves in four to eight weeks without treatment and patient enters into asymptomatic latent phase. About a quarter of patients may develop recurrence of similar symptoms in one year. If left untreated, 35% of patients may develop tertiary syphilis which include complications such as cardiovascular involvement, neurologic infection and gummatous lesions involving skin, bone and joints which is associated with significant [[morbidity]] and [[mortality]].<ref name="pmid17235095">{{cite journal| author=French P| title=Syphilis. | journal=BMJ | year= 2007 | volume= 334 | issue= 7585 | pages= 143-7 | pmid=17235095 | doi=10.1136/bmj.39085.518148.BE | pmc=1779891 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17235095  }} </ref><ref name="pmid1951814">{{cite journal| author=Thomas SB, Quinn SC| title=The Tuskegee Syphilis Study, 1932 to 1972: implications for HIV education and AIDS risk education programs in the black community. | journal=Am J Public Health | year= 1991 | volume= 81 | issue= 11 | pages= 1498-505 | pmid=1951814 | doi= | pmc=1405662 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1951814  }} </ref><ref name="pmid13301322">{{cite journal| author=GJESTLAND T| title=The Oslo study of untreated syphilis; an epidemiologic investigation of the natural course of the syphilitic infection based upon a re-study of the Boeck-Bruusgaard material. | journal=Acta Derm Venereol Suppl (Stockh) | year= 1955 | volume= 35 | issue= Suppl 34 | pages= 3-368; Annex I-LVI | pmid=13301322 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=13301322  }} </ref> The prognosis of syphilis varies by stage of disease.Prognosis of primary and secondary syphilis is good with treatment. For tertiary syphilis, prognosis varies by site of involvememnt and duration of disease. 90% of patients with neurosyphilis respond to treatment. However, mortality rates are high with cardio vascular complications.<ref name="pmid1951814">{{cite journal| author=Thomas SB, Quinn SC| title=The Tuskegee Syphilis Study, 1932 to 1972: implications for HIV education and AIDS risk education programs in the black community. | journal=Am J Public Health | year= 1991 | volume= 81 | issue= 11 | pages= 1498-505 | pmid=1951814 | doi= | pmc=1405662 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1951814 }} </ref><ref name="pmid13301322">{{cite journal| author=GJESTLAND T| title=The Oslo study of untreated syphilis; an epidemiologic investigation of the natural course of the syphilitic infection based upon a re-study of the Boeck-Bruusgaard material. | journal=Acta Derm Venereol Suppl (Stockh) | year= 1955 | volume= 35 | issue= Suppl 34 | pages= 3-368; Annex I-LVI | pmid=13301322 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=13301322  }} </ref><ref name="pmid10194456">{{cite journal| author=Singh AE, Romanowski B| title=Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features. | journal=Clin Microbiol Rev | year= 1999 | volume= 12 | issue= 2 | pages= 187-209 | pmid=10194456 | doi= | pmc=88914 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10194456 }} </ref>
Initial presentation of syphilis is appearance of painless chancre after 3-4 weeks of exposure. If left untreated, chancre self resolves and may progress to develop [[constitutional sypmtoms]] and generalised symmetric rash in four to eight weeks. In less than 10% of individuals, complications such as [[hepatitis]], [[iritis]], [[nephritis]], and neurological problems may develop at this stage. However, it resolves in four to eight weeks without treatment and patient enters into asymptomatic latent phase. About a quarter of patients may develop recurrence of similar symptoms in one year. If left untreated, 35% of patients may develop tertiary syphilis which include complications such as cardiovascular involvement, neurologic infection and gummatous lesions involving skin, bone and joints which is associated with significant [[morbidity]] and [[mortality]]. The prognosis of syphilis varies by stage of disease.Prognosis of primary and secondary syphilis is good with treatment. For tertiary syphilis, prognosis varies by site of involvememnt and duration of disease. 90% of patients with neurosyphilis respond to treatment. However, mortality rates are high with cardio vascular complications.<ref name="pmid1951814">{{cite journal| author=Thomas SB, Quinn SC| title=The Tuskegee Syphilis Study, 1932 to 1972: implications for HIV education and AIDS risk education programs in the black community. | journal=Am J Public Health | year= 1991 | volume= 81 | issue= 11 | pages= 1498-505 | pmid=1951814 | doi= | pmc=1405662 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1951814  }} </ref><ref name="pmid13301322">{{cite journal| author=GJESTLAND T| title=The Oslo study of untreated syphilis; an epidemiologic investigation of the natural course of the syphilitic infection based upon a re-study of the Boeck-Bruusgaard material. | journal=Acta Derm Venereol Suppl (Stockh) | year= 1955 | volume= 35 | issue= Suppl 34 | pages= 3-368; Annex I-LVI | pmid=13301322 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=13301322  }} </ref><ref name="pmid10194456">{{cite journal| author=Singh AE, Romanowski B| title=Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features. | journal=Clin Microbiol Rev | year= 1999 | volume= 12 | issue= 2 | pages= 187-209 | pmid=10194456 | doi= | pmc=88914 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10194456 }} </ref><ref name="pmid17235095">{{cite journal| author=French P| title=Syphilis. | journal=BMJ | year= 2007 | volume= 334 | issue= 7585 | pages= 143-7 | pmid=17235095 | doi=10.1136/bmj.39085.518148.BE | pmc=1779891 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17235095 }} </ref>


==Natural history==
==Natural history==

Revision as of 18:43, 28 September 2016

Sexually transmitted diseases Main Page

Syphilis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Syphilis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary and Secondary Syphilis
Latent Syphilis
Tertiary Syphilis
Neurosyphilis
HIV-Infected Patients
Pregnancy
Management of Sexual Partners

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Syphilis natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Syphilis natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Syphilis natural history, complications and prognosis

CDC on Syphilis natural history, complications and prognosis

Syphilis natural history, complications and prognosis in the news

Blogs on Syphilis natural history, complications and prognosis

Directions to Hospitals Treating Syphilis

Risk calculators and risk factors for Syphilis natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]

Overview

Initial presentation of syphilis is appearance of painless chancre after 3-4 weeks of exposure. If left untreated, chancre self resolves and may progress to develop constitutional sypmtoms and generalised symmetric rash in four to eight weeks. In less than 10% of individuals, complications such as hepatitis, iritis, nephritis, and neurological problems may develop at this stage. However, it resolves in four to eight weeks without treatment and patient enters into asymptomatic latent phase. About a quarter of patients may develop recurrence of similar symptoms in one year. If left untreated, 35% of patients may develop tertiary syphilis which include complications such as cardiovascular involvement, neurologic infection and gummatous lesions involving skin, bone and joints which is associated with significant morbidity and mortality. The prognosis of syphilis varies by stage of disease.Prognosis of primary and secondary syphilis is good with treatment. For tertiary syphilis, prognosis varies by site of involvememnt and duration of disease. 90% of patients with neurosyphilis respond to treatment. However, mortality rates are high with cardio vascular complications.[1][2][3][4]

Natural history

Initial presentation of syphilis is appearance of painless chancre after 3-4 weeks of exposure. If left untreated, chancre self resolves and may progress to develop constitutional sypmtoms and generalised symmetric rash in four to eight weeks. In less than 10% of individuals, complications such as hepatitis, iritis, nephritis, and neurological problems may develop at this stage. However, it resolves in four to eight weeks without treatment and patient enters into asymptomatic latent phase. About a quarter of patients may develop recurrence of similar symptoms in one year. If left untreated, 35% of patients may develop tertiary syphilis which include complications such as cardiovascular involvement in 15-30 years(80-85%, aortic aneurysm, aortic regurgitation, angina, heart failure), neurologic infection in 10-15 years (5-10%, cranial nerve dysfunction, meningitis, stroke, acute or chronic altered mental status, loss of vibration sense, and auditory or ophthalmic abnormalities) and gummatous lesions involving skin, bone and joints which is associated with significant morbidity and mortality.[4][1][2][3]

Complications

Complications that can develop as a result of syphilis are:

Ocular

Auditory

Neurological

Cardiovascular

Renal

Musculoskeletal

Dermatological

Gastrintestinal

Gummatous lesions

Prognosis

The prognosis of syphilis varies by stage of disease:[1][2][3]

Primary and secondary syphilis

Prognosis is good with treatment.

Tertiary syphilis

Prognosis varies by site of involvememnt and duration of disease:

  • 90% of patients with neurosyphilis respond to treatment.
  • Gummatous lesions reverse with treatment.
  • Mortality rates are high with cardiovascular complications.
  • 20% of patients with tertiary syphilis die of complications.

References

  1. 1.0 1.1 1.2 Thomas SB, Quinn SC (1991). "The Tuskegee Syphilis Study, 1932 to 1972: implications for HIV education and AIDS risk education programs in the black community". Am J Public Health. 81 (11): 1498–505. PMC 1405662. PMID 1951814.
  2. 2.0 2.1 2.2 GJESTLAND T (1955). "The Oslo study of untreated syphilis; an epidemiologic investigation of the natural course of the syphilitic infection based upon a re-study of the Boeck-Bruusgaard material". Acta Derm Venereol Suppl (Stockh). 35 (Suppl 34): 3–368, Annex I-LVI. PMID 13301322.
  3. 3.0 3.1 3.2 3.3 3.4 Singh AE, Romanowski B (1999). "Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features". Clin Microbiol Rev. 12 (2): 187–209. PMC 88914. PMID 10194456.
  4. 4.0 4.1 French P (2007). "Syphilis". BMJ. 334 (7585): 143–7. doi:10.1136/bmj.39085.518148.BE. PMC 1779891. PMID 17235095.
  5. Kiss S, Damico FM, Young LH (2005). "Ocular manifestations and treatment of syphilis". Semin Ophthalmol. 20 (3): 161–7. doi:10.1080/08820530500232092. PMID 16282150.
  6. Balba GP, Kumar PN, James AN, Malani A, Palestine AG, Welch JN; et al. (2006). "Ocular syphilis in HIV-positive patients receiving highly active antiretroviral therapy". Am J Med. 119 (5): 448.e21–5. doi:10.1016/j.amjmed.2005.11.016. PMID 16651059.
  7. Westeneng AC, Rothova A, de Boer JH, de Groot-Mijnes JD (2007). "Infectious uveitis in immunocompromised patients and the diagnostic value of polymerase chain reaction and Goldmann-Witmer coefficient in aqueous analysis". Am J Ophthalmol. 144 (5): 781–5. doi:10.1016/j.ajo.2007.06.034. PMID 17707328.
  8. Schlaegel TF, Kao SF (1982). "A review (1970-1980) of 28 presumptive cases of syphilitic uveitis". Am J Ophthalmol. 93 (4): 412–4. PMID 7072806.
  9. Deschenes J, Seamone CD, Baines MG (1992). "Acquired ocular syphilis: diagnosis and treatment". Ann Ophthalmol. 24 (4): 134–8. PMID 1590633.
  10. Moore, Joseph Earle. "Syphilitic iritis: a study of 249 patients." American Journal of Ophthalmology 14.2 (1931): 110-126.
  11. Morrison AW (1992). "On syphilis and the ear--an otologist's view". Genitourin Med. 68 (6): 420–2. PMC 1194985. PMID 1487268.
  12. Berger JR, Dean D (2014). "Neurosyphilis". Handb Clin Neurol. 121: 1461–72. doi:10.1016/B978-0-7020-4088-7.00098-5. PMID 24365430.
  13. Simon RP (1985). "Neurosyphilis". Arch Neurol. 42 (6): 606–13. PMID 3890813.
  14. Lukehart SA, Hook EW, Baker-Zander SA, Collier AC, Critchlow CW, Handsfield HH (1988). "Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment". Ann Intern Med. 109 (11): 855–62. PMID 3056164.
  15. Loewenfeld IE (1969). "The Argyll Robertson pupil 1869-1969. A critical survey of the literature". Surv Ophthalmol. 14 (3): 199–299. PMID 19093312.
  16. Hotson JR (1981). "Modern neurosyphilis: a partially treated chronic meningitis". West J Med. 135 (3): 191–200. PMC 1273113. PMID 7340118.
  17. 17.0 17.1 Musher, Daniel M., Richard J. Hamill, and Robert E. Baughn. "Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment." Annals of Internal Medicine 113.11 (1990): 872-881.
  18. Katz, Debra A., Joseph R. Berger, and Robert C. Duncan. "Neurosyphilis: a comparative study of the effects of infection with human immunodeficiency virus." Archives of neurology 50.3 (1993): 243-249.
  19. Sapira JD (1981 Apr). ""Quincke, de Musset, Duroziez, and Hill: some aortic regurgitations"". South Med J. 74 (4): 459–67. Check date values in: |date= (help)
  20. Pugh PJ, Grech ED (2002). "Images in clinical medicine. Syphilitic aortitis". N Engl J Med. 346 (9): 676. doi:10.1056/NEJMicm010343. PMID 11870245.
  21. Kennedy JL, Barnard JJ, Prahlow JA (2006). "Syphilitic coronary artery ostial stenosis resulting in acute myocardial infarction and death". Cardiology. 105 (1): 25–9. doi:10.1159/000088337. PMID 16179782.
  22. "Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 10-1998. A 46-year-old man with chest pain and coronary ostial stenosis". N Engl J Med. 338 (13): 897–903. 1998. doi:10.1056/NEJM199803263381308. PMID 9518283.
  23. Burch, George E., and Travis Winsor. "Syphilitic coronary stenosis, with myocardial infarction." American Heart Journal 24.6 (1942): 740-751.
  24. Hunte W, al-Ghraoui F, Cohen RJ (1993). "Secondary syphilis and the nephrotic syndrome". J Am Soc Nephrol. 3 (7): 1351–5. PMID 8439646.
  25. Reginato AJ (1993). "Syphilitic arthritis and osteitis". Rheum Dis Clin North Am. 19 (2): 379–98. PMID 8502778.
  26. Mindel A, Tovey SJ, Timmins DJ, Williams P (1989). "Primary and secondary syphilis, 20 years' experience. 2. Clinical features". Genitourin Med. 65 (1): 1–3. PMC 1196177. PMID 2921046.
  27. 27.0 27.1 27.2 Wöhrl S, Geusau A (2007). "Clinical update: syphilis in adults". Lancet. 369 (9577): 1912–4. doi:10.1016/S0140-6736(07)60895-2. PMID 17560432.
  28. 28.0 28.1 Chapel TA (1980). "The signs and symptoms of secondary syphilis". Sex Transm Dis. 7 (4): 161–4. PMID 7455863.
  29. http://medical-dictionary.thefreedictionary.com/Lues+maligna
  30. Pleimes M, Hartschuh W, Kutzner H, Enk AH, Hartmann M (2009). "Malignant syphilis with ocular involvement and organism-depleted lesions". Clin Infect Dis. 48 (1): 83–5. doi:10.1086/594127. PMID 19035775.
  31. Fisher DA, Chang LW, Tuffanelli DL (1969). "Lues maligna. Presentation of a cas and a review of the literature". Arch Dermatol. 99 (1): 70–3. PMID 5761808.
  32. Young MF, Sanowski RA, Manne RA (1992). "Syphilitic hepatitis". J Clin Gastroenterol. 15 (2): 174–6. PMID 1401840, Check |pmid= value (help).
  33. Campisi D, Whitcomb C (1979). "Liver disease in early syphilis". Arch Intern Med. 139 (3): 365–6. PMID 426583.
  34. Greenstein DB, Wilcox CM, Schwartz DA (1994). "Gastric syphilis. Report of seven cases and review of the literature". J Clin Gastroenterol. 18 (1): 4–9. PMID 8113584.
  35. Winters HA, Notar-Francesco V, Bromberg K, Rawstrom SA, Vetrano J, Prego V; et al. (1992). "Gastric syphilis: five recent cases and a review of the literature". Ann Intern Med. 116 (4): 314–9. PMID 1733388.
  36. Zhang L, Zhou Y, Chen J, Yan W, Kong Q, Chen P; et al. (2016). "A case of a cerebral syphilitic gumma developed in a few months mimicking a brain tumor in a human immunodeficiency virus-negative patient". Br J Neurosurg: 1–3. doi:10.3109/02688697.2016.1173190. PMID 27088540.

Template:WH

Template:WS